Covered recipient · General Payments record
ANNA IONES
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$3,646.94
- Reported across 235 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $526.67 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $154.74 | 11 |
| ABBVIE INC. | $134.94 | 10 |
| Lilly USA, LLC | $66.29 | 4 |
| Teva Pharmaceuticals USA, Inc. | $46.33 | 3 |
| Lundbeck LLC | $30.68 | 2 |
| Neurocrine BioSciences, Inc. | $16.92 | 1 |
| Otsuka America Pharmaceutical, Inc. | $16.28 | 1 |
| UCB, Inc. | $16.23 | 1 |
| ARGENX US, INC. | $15.85 | 1 |
| EISAI INC. | $14.83 | 1 |
| Neurelis, Inc. | $13.58 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.93 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103968283 | CMS |
| ABBVIE INC. | $8.65 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103968285 | CMS |
| ABBVIE INC. | $15.67 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103968287 | CMS |
| ABBVIE INC. | $14.37 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103968289 | CMS |
| ABBVIE INC. | $17.40 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103968291 | CMS |
| ABBVIE INC. | $12.00 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103968293 | CMS |
| ABBVIE INC. | $7.03 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103968295 | CMS |
| ABBVIE INC. | $10.33 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103968297 | CMS |
| ABBVIE INC. | $15.18 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103968299 | CMS |
| ABBVIE INC. | $18.38 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103968301 | CMS |
| ARGENX US, INC. | $15.85 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142111577 | CMS |
| Eisai Inc. | $14.83 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110730365 | CMS |
| Lilly USA, LLC | $16.58 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136044252 | CMS |
| Lilly USA, LLC | $14.47 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136044254 | CMS |
| Lilly USA, LLC | $18.40 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136048393 | CMS |
| Lilly USA, LLC | $16.84 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135999579 | CMS |
| Lundbeck LLC | $16.38 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145927624 | CMS |
| Lundbeck LLC | $14.30 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145927626 | CMS |
| Neurelis, Inc. | $13.58 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145643950 | CMS |
| Neurocrine Biosciences, Inc. | $16.92 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150869198 | CMS |
| Otsuka America Pharmaceutical, Inc. | $16.28 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118912373 | CMS |
| PFIZER INC. | $11.94 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130896174 | CMS |
| PFIZER INC. | $16.67 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131109121 | CMS |
| PFIZER INC. | $9.99 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131266289 | CMS |
| PFIZER INC. | $18.24 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131376617 | CMS |
| PFIZER INC. | $16.48 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131512347 | CMS |
| PFIZER INC. | $13.37 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131652892 | CMS |
| PFIZER INC. | $8.52 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130924059 | CMS |
| PFIZER INC. | $9.12 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130967883 | CMS |
| PFIZER INC. | $15.71 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131944638 | CMS |
| PFIZER INC. | $17.35 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131062137 | CMS |
| PFIZER INC. | $17.35 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131097061 | CMS |
| Teva Pharmaceuticals USA, Inc. | $14.58 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151593051 | CMS |
| Teva Pharmaceuticals USA, Inc. | $15.38 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151593065 | CMS |
| Teva Pharmaceuticals USA, Inc. | $16.37 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151593159 | CMS |
| UCB, Inc. | $16.23 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143217059 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.